. . "imitations represented nearly 63% of the weight for these comparisons.28,29 Our results are particularly applicable because they contradict the recommendation by the Surviving Sepsis Campaign favoring PPIs.30 A large randomized study comparing these 2 classes of agents and powered for clinically significant GI hemorrhage and infectious complications is warranted." . .